0 CHECKOUT

Digestive Remedies in the Netherlands

  • ID: 316790
  • November 2015
  • Region: Netherlands, Holland
  • 29 pages
  • Euromonitor International
1 of 3

Value growth remained strong and healthy in digestive remedies in 2015. The 5% current value growth recorded in the category in 2015 was in line with the 5% current value CAGR recorded in the category over the entire review period. While most Dutch consumers still prefer prescription drugs over OTC drugs when faced with digestive problems, the innate price-consciousness of many Dutch consumers has driven them towards OTC.

The Digestive Remedies in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Digestive Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown
2 of 3

DIGESTIVE REMEDIES IN THE NETHERLANDS

November 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2010-2015
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2010-2015
Table 3 NBO Company Shares of Digestive Remedies: % Value 2011-2015
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2012-2015
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2015-2020
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2015-2020
Omega Pharma Nederland BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 1 Omega Pharma Nederland BV: Key Facts
Competitive Positioning
Summary 2 Omega Pharma Nederland BV: Competitive Position 2015
Pfizer BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 3 Pfizer BV: Key Facts
Competitive Positioning
Summary 4 Pfizer BV: Competitive Position 2015
Vemedia BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 5 Vemedia BV: Key Facts
Competitive Positioning
Summary 6 Vemedia BV: Competitive Position 2015
Executive Summary
Consumer Health Registers Positive Value Growth During 2015
Demographic Changes and Weather Conditions Fuel Sales in Consumer Health
Consumer Health Remains Highly Fragmented Despite Recent Acquisitions
the Importance of Internet Retailing Rises in the Retail Distribution of Consumer Health
Consumer Health Likely To Experience Moderate Value Growth Over the Forecast Period
Key Trends and Developments
the Ageing Dutch Population
Consumers Are Adopting the Healthy Lifestyle Trend
A Shift in Focus Away From Treatment Towards Prevention
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
Table 8 Life Expectancy at Birth 2010-2015
Market Data
Table 9 Sales of Consumer Health by Category: Value 2010-2015
Table 10 Sales of Consumer Health by Category: % Value Growth 2010-2015
Table 11 NBO Company Shares of Consumer Health: % Value 2011-2015
Table 12 LBN Brand Shares of Consumer Health: % Value 2012-2015
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2010-2015
Table 14 Distribution of Consumer Health by Format: % Value 2010-2015
Table 15 Distribution of Consumer Health by Format and Category: % Value 2015
Table 16 Forecast Sales of Consumer Health by Category: Value 2015-2020
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2015-2020
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 7 OTC: Switches 2013-2015
Sources
Summary 8 Research Sources

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer Inc.
  • Boehringer Ingelheim GmbH